These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 9710605)

  • 1. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.
    Gale M; Blakely CM; Kwieciszewski B; Tan SL; Dossett M; Tang NM; Korth MJ; Polyak SJ; Gretch DR; Katze MG
    Mol Cell Biol; 1998 Sep; 18(9):5208-18. PubMed ID: 9710605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.
    Gale MJ; Korth MJ; Katze MG
    Clin Diagn Virol; 1998 Jul; 10(2-3):157-62. PubMed ID: 9741641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
    Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
    J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.
    Gale MJ; Korth MJ; Tang NM; Tan SL; Hopkins DA; Dever TE; Polyak SJ; Gretch DR; Katze MG
    Virology; 1997 Apr; 230(2):217-27. PubMed ID: 9143277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR.
    Sudha G; Yamunadevi S; Tyagi N; Das S; Srinivasan N
    BMC Struct Biol; 2012 Nov; 12():28. PubMed ID: 23148689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication.
    Polyak SJ; Paschal DM; McArdle S; Gale MJ; Moradpour D; Gretch DR
    Hepatology; 1999 Apr; 29(4):1262-71. PubMed ID: 10094974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.
    He Y; Tan SL; Tareen SU; Vijaysri S; Langland JO; Jacobs BL; Katze MG
    J Virol; 2001 Jun; 75(11):5090-8. PubMed ID: 11333890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.
    Yokozaki S; Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
    J Med Virol; 2011 Oct; 83(10):1727-32. PubMed ID: 21837788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells.
    Noguchi T; Satoh S; Noshi T; Hatada E; Fukuda R; Kawai A; Ikeda S; Hijikata M; Shimotohno K
    Microbiol Immunol; 2001; 45(12):829-40. PubMed ID: 11838900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.
    Duverlie G; Khorsi H; Castelain S; Jaillon O; Izopet J; Lunel F; Eb F; Penin F; Wychowski C
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1373-81. PubMed ID: 9634077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?
    Squadrito G; Raffa G; Restuccia T; Pollicino T; Brancatelli S; Raimondo G
    J Viral Hepat; 2002 Sep; 9(5):360-9. PubMed ID: 12225331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.
    François C; Duverlie G; Rebouillat D; Khorsi H; Castelain S; Blum HE; Gatignol A; Wychowski C; Moradpour D; Meurs EF
    J Virol; 2000 Jun; 74(12):5587-96. PubMed ID: 10823866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner.
    Taguchi T; Nagano-Fujii M; Akutsu M; Kadoya H; Ohgimoto S; Ishido S; Hotta H
    J Gen Virol; 2004 Apr; 85(Pt 4):959-969. PubMed ID: 15039538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
    Nousbaum J; Polyak SJ; Ray SC; Sullivan DG; Larson AM; Carithers RL; Gretch DR
    J Virol; 2000 Oct; 74(19):9028-38. PubMed ID: 10982347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/ribavirin therapy.
    Bouzgarrou N; Hassen E; Mahfoudh W; Gabbouj S; Schvoerer E; Ben Yahia A; Ben Mami N; Triki H; Chouchane L
    J Med Virol; 2009 Dec; 81(12):2021-8. PubMed ID: 19856481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.
    Giménez-Barcons M; Franco S; Suárez Y; Forns X; Ampurdanès S; Puig-Basagoiti F; Sánchez-Fueyo A; Barrera JM; Llovet JM; Bruix J; Sánchez-Tapias JM; Rodés J; Saiz JC
    Hepatology; 2001 Jul; 34(1):158-67. PubMed ID: 11431747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity.
    Castelain S; Khorsi H; Roussel J; François C; Jaillon O; Capron D; Penin F; Wychowski C; Meurs E; Duverlie G;
    J Infect Dis; 2002 Mar; 185(5):573-83. PubMed ID: 11865413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin.
    Hung CH; Lee CM; Lu SN; Lee JF; Wang JH; Tung HD; Chen TM; Hu TH; Chen WJ; Changchien CS
    J Viral Hepat; 2003 Mar; 10(2):87-94. PubMed ID: 12614464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment.
    Berg T; Mas Marques A; Höhne M; Wiedenmann B; Hopf U; Schreier E
    Hepatology; 2000 Dec; 32(6):1386-95. PubMed ID: 11093746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.